Sign Up to like & get
recommendations!
0
Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.02.010
Abstract: Primary plasma cell leukemia (PPCL) is a rare form of multiple myeloma with a dismal prognosis. This retrospective multi-center study examines the national experience of PPCL in the era of novel agents. During 2002-2016, thirty-nine…
read more here.
Keywords:
primary plasma;
cell leukemia;
novel agents;
plasma cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Leukemia research"
DOI: 10.1016/j.leukres.2018.09.007
Abstract: Primary plasma cell leukemia (pPCL) is a rare and very aggressive variant of multiple myeloma (MM). Specific clinical, biological and molecular patterns distinguish pPCL from MM. Here, we performed a genome-wide methylation analysis by high-density…
read more here.
Keywords:
ppcl;
primary plasma;
methylation;
cell leukemia ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood Cancer Journal"
DOI: 10.1038/s41408-019-0253-1
Abstract: Primary plasma cell leukemia (pPCL) is a highly aggressive plasma cell dyscrasia characterised by short remissions and very poor survival. Although the 17p deletion is associated with poor outcome and extramedullary disease in MM, its…
read more here.
Keywords:
primary plasma;
significant differences;
analysis;
plasma cell ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood"
DOI: 10.1182/blood.2021014968
Abstract: Primary plasma cell leukemia (pPCL) is an aggressive form of multiple myeloma (MM) that has not benefited from recent therapeutic advances in the field. Because very rare and heterogeneous, it remains poorly understood at the…
read more here.
Keywords:
specific genomic;
plasma cell;
cell leukemia;
plasma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2022.42.2.278
Abstract: Dear Editor, Acute promyelocytic leukemia (APL) is frequently associated with disseminated intravascular coagulation (DIC) and hemorrhage, which contributes to its high mortality rate [1]. Molecular confirmation for identifying a PML-RARA rearrangement has to be performed…
read more here.
Keywords:
cell;
promyelocytic leukemia;
leukemia;
plasma cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancers"
DOI: 10.3390/cancers13194898
Abstract: Simple Summary The growing interest in BCL2 inhibitors for the treatment of multiple myeloma (MM) has led to the need for biomarkers that are able to predict patient’s sensitivity to the drug. The presence of…
read more here.
Keywords:
primary plasma;
cell leukemia;
plasma cell;
sensitivity ... See more keywords